Clinical Trial Update: Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating Henagliflozin for weight loss in obesity, with not yet recruiting status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Pre-diabetes
• Weight Gain Due to Obesity

Drugs mentioned

• Henagliflozin (henagliflozin)

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Obese, Weight Loss | Phase 4 | Status: NOT_YET_RECRUITING